Biotecnología Aplicada ()

An open, non-controlled clinical study to assess the efficacy and safety of the recombinant human alpha 2b pegylated interferon PEG-Heberon® plus ribavirin for the treatment of chronic hepatitis C virus infection in Cuban patients

  • Marlen I Castellanos-Fernández,
  • Ariadna González-García,
  • Hugo Nodarse-Cuní,
  • Luis Calzadilla-Bertot,
  • Yadina Martínez-Pérez,
  • Yoan A Sánchez Rodríguez,
  • Zaily Dorta-Guridi,
  • Ana L Torres González,
  • Enrique R Arús Soler,
  • Yaritza López Díaz

Journal volume & issue
Vol. 32, no. 4
pp. 4201 – 4207

Abstract

Read online

No abstracts available.

Keywords